After Aβ immunotherapy, only four markers were modified when compared with unimmunised AD, with increased expression of the pro-inflammatory chemokine IL8, the anti-inflammatory cytokine IL13, the vascular endothelial growth factor (VEGF), and a decrease in the pro-inflammatory cytokine IL7. Here, IL13 is linked to Alzheimer disease.